Thermo Fisher Scientific Inc. (LON:0R0H)

London flag London · Delayed Price · Currency is GBP · Price in USD
511.12
-4.93 (-0.96%)
Mar 27, 2025, 7:11 PM BST
-10.31%
Market Cap 148.94B
Revenue (ttm) 34.25B
Net Income (ttm) 5.06B
Shares Out n/a
EPS (ttm) 13.20
PE Ratio 29.43
Forward PE n/a
Dividend 1.25 (0.24%)
Ex-Dividend Date Mar 14, 2025
Volume 566
Average Volume 2,395
Open 510.86
Previous Close 516.05
Day's Range 508.04 - 514.22
52-Week Range 416.66 - 603.14
Beta 0.79
RSI 38.52
Earnings Date Apr 23, 2025

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1956
Employees 125,000
Stock Exchange London Stock Exchange
Ticker Symbol 0R0H
Full Company Profile

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD Financial Statements

News

Thermo Fisher Scientific and Chan Zuckerberg Institute for Advanced Biological Imaging Collaborate to Further Understanding of Human Cells

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biolo...

1 day ago - Business Wire

Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the launch of the Thermo Scientific Vulcan™ Automated...

10 days ago - Business Wire

Is the Market Bullish or Bearish on Thermo Fisher Scientific?

Thermo Fisher Scientific's (NYSE: TMO) short percent of float has risen 7.84% since its last report. The company recently reported that it has 4.15 million shares sold short , which is 1.1% of all re...

14 days ago - Benzinga

Market Whales and Their Recent Bets on TMO Options

Whales with a lot of money to spend have taken a noticeably bullish stance on Thermo Fisher Scientific . Looking at options history for Thermo Fisher Scientific (NYSE: TMO) we detected 14 trades. If ...

15 days ago - Benzinga

Buy Two Ideal March 'Safer' Dividend Dogs Of 34 Barron's 2025 Pro-Picks

Barron's New-Year (NY) Roundtable (RT) selections published in three issues 1/13-27/2025, listed 34 dividend picks as the best of 2025. Analysts predict top picks like AdvanSix, Applied Materials, and...

21 days ago - Seeking Alpha

Thermo Fisher Scientific: Strong Q4, Strategic M&A, And Poised For Growth In Life Sciences

Thermo Fisher's Q4 & FY’24 results showcase growth potential with 12% IRR, strategic acquisitions, and undervalued stock. Read more on TMO stock here.

21 days ago - Seeking Alpha

Invest with Confidence: Intrinsic Value Unveiled of Thermo Fisher Scientific Inc

Invest with Confidence: Intrinsic Value Unveiled of Thermo Fisher Scientific Inc

23 days ago - GuruFocus

Solventum Corporation (SOLV) Announces $4.10 Billion Asset Sale to Thermo Fisher Scientific

Solventum Corporation (SOLV) Announces $4.10 Billion Asset Sale to Thermo Fisher Scientific

4 weeks ago - GuruFocus

Trian Comments on Solventum's Sale of its Purification & Filtration Business

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company's...

4 weeks ago - GlobeNewsWire

Thermo Fisher Scientific Launches CorEvitas Clinical Registry and Biorepository in Systemic Lupus Erythematosus

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus Registry.

4 weeks ago - Business Wire

Unlocking Intrinsic Value: Analysis of Thermo Fisher Scientific Inc

Unlocking Intrinsic Value: Analysis of Thermo Fisher Scientific Inc

4 weeks ago - GuruFocus

Solventum Stock Jumps After $4.1B Deal With Thermo Fisher

Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said it would acquire the company’s purification and filtration business for $4....

4 weeks ago - Investopedia

Thermo Fisher Strikes Deal for Solventums Filtration Unit

4 weeks ago - The Wall Street Journal

Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion

Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion.

4 weeks ago - Reuters

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

Accelerates Solventum's business transformation and sharpens focus on strategic areas for growth to deliver long-term shareholder value Strengthens balance sheet with proceeds to be used primarily for...

4 weeks ago - PRNewsWire

Thermo Fisher Scientific to Acquire Solventum's Purification and Filtration Business

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a definitive agreem...

4 weeks ago - Business Wire

Thermo Fisher Scientific Inc (TMO) to Present at TD Cowen 45th Annual Health Care Conference

Thermo Fisher Scientific Inc (TMO) to Present at TD Cowen 45th Annual Health Care Conference

4 weeks ago - GuruFocus

Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...

4 weeks ago - Business Wire

Thermo Fisher Scientific Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on Thermo Fisher Scientific (NYSE: TMO). And retail traders should know. We noticed this today when the trades showed up on publicly...

5 weeks ago - Benzinga

Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT Insight

Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT Insight

5 weeks ago - GuruFocus